Search Reports
Categories
Categories

Global Genomic Biomarker Market

Global Genomic Biomarker Market Research Report 2025(Status and Outlook)

Report Code : MEC1082
Published Date : 17 July, 1905 | No of Pages: 158

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Genomic biomarkers are specific DNA or RNA sequences, gene mutations, or expression patterns that can be used to identify disease risk, predict treatment response, or monitor disease progression. These biomarkers play a crucial role in precision medicine, enabling personalized treatment strategies by providing insights into an individual\'s genetic makeup and its association with diseases such as cancer, cardiovascular disorders, and neurological conditions. The market for genomic biomarkers is driven by advancements in next-generation sequencing (NGS), increasing adoption of companion diagnostics, and growing demand for targeted therapies. Key applications include oncology, pharmacogenomics, and infectious disease testing, with oncology being the dominant segment due to the rising prevalence of cancer and the need for early detection and tailored treatments. The competitive landscape includes major biotechnology firms, diagnostic companies, and pharmaceutical players investing heavily in research and development to enhance biomarker discovery and validation. However, challenges such as high costs, regulatory hurdles, and data privacy concerns may hinder market growth. Despite these barriers, the increasing focus on precision medicine and the integration of artificial intelligence for biomarker analysis are expected to drive significant expansion in the coming years.

The global Genomic Biomarker market size was estimated at USD 2502.75 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Genomic Biomarker market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Genomic Biomarker market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Genomic Biomarker market.
Global Genomic Biomarker Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina

Market Segmentation (by Type)
Protein Marker
Nucleic Acid Marker
Other

Market Segmentation (by Application)
Hospitals
Diagnostic and research laboratories

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Genomic Biomarker Market
Overview of the regional outlook of the Genomic Biomarker Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genomic Biomarker Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Genomic Biomarker, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Genomic Biomarker
      1.2 Key Market Segments
            1.2.1 Genomic Biomarker Segment by Type
            1.2.2 Genomic Biomarker Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Genomic Biomarker Market Overview
      2.1 Global Market Overview
            2.1.1 Global Genomic Biomarker Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Genomic Biomarker Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Genomic Biomarker Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Genomic Biomarker Product Life Cycle
      3.3 Global Genomic Biomarker Sales by Manufacturers (2020-2025)
      3.4 Global Genomic Biomarker Revenue Market Share by Manufacturers (2020-2025)
      3.5 Genomic Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Genomic Biomarker Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Genomic Biomarker Market Competitive Situation and Trends
            3.8.1 Genomic Biomarker Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Genomic Biomarker Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Genomic Biomarker Industry Chain Analysis
      4.1 Genomic Biomarker Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Genomic Biomarker Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Genomic Biomarker Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Genomic Biomarker Market
      5.7 ESG Ratings of Leading Companies
  6 Genomic Biomarker Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Genomic Biomarker Sales Market Share by Type (2020-2025)
      6.3 Global Genomic Biomarker Market Size Market Share by Type (2020-2025)
      6.4 Global Genomic Biomarker Price by Type (2020-2025)
  7 Genomic Biomarker Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Genomic Biomarker Market Sales by Application (2020-2025)
      7.3 Global Genomic Biomarker Market Size (M USD) by Application (2020-2025)
      7.4 Global Genomic Biomarker Sales Growth Rate by Application (2020-2025)
  8 Genomic Biomarker Market Sales by Region
      8.1 Global Genomic Biomarker Sales by Region
            8.1.1 Global Genomic Biomarker Sales by Region
            8.1.2 Global Genomic Biomarker Sales Market Share by Region
      8.2 Global Genomic Biomarker Market Size by Region
            8.2.1 Global Genomic Biomarker Market Size by Region
            8.2.2 Global Genomic Biomarker Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Genomic Biomarker Sales by Country
            8.3.2 North America Genomic Biomarker Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Genomic Biomarker Sales by Country
            8.4.2 Europe Genomic Biomarker Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Genomic Biomarker Sales by Region
            8.5.2 Asia Pacific Genomic Biomarker Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Genomic Biomarker Sales by Country
            8.6.2 South America Genomic Biomarker Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Genomic Biomarker Sales by Region
            8.7.2 Middle East and Africa Genomic Biomarker Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Genomic Biomarker Market Production by Region
      9.1 Global Production of Genomic Biomarker by Region(2020-2025)
      9.2 Global Genomic Biomarker Revenue Market Share by Region (2020-2025)
      9.3 Global Genomic Biomarker Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Genomic Biomarker Production
            9.4.1 North America Genomic Biomarker Production Growth Rate (2020-2025)
            9.4.2 North America Genomic Biomarker Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Genomic Biomarker Production
            9.5.1 Europe Genomic Biomarker Production Growth Rate (2020-2025)
            9.5.2 Europe Genomic Biomarker Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Genomic Biomarker Production (2020-2025)
            9.6.1 Japan Genomic Biomarker Production Growth Rate (2020-2025)
            9.6.2 Japan Genomic Biomarker Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Genomic Biomarker Production (2020-2025)
            9.7.1 China Genomic Biomarker Production Growth Rate (2020-2025)
            9.7.2 China Genomic Biomarker Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Bio-Rad
            10.1.1 Bio-Rad Basic Information
            10.1.2 Bio-Rad Genomic Biomarker Product Overview
            10.1.3 Bio-Rad Genomic Biomarker Product Market Performance
            10.1.4 Bio-Rad Business Overview
            10.1.5 Bio-Rad SWOT Analysis
            10.1.6 Bio-Rad Recent Developments
      10.2 Beckman Coulter
            10.2.1 Beckman Coulter Basic Information
            10.2.2 Beckman Coulter Genomic Biomarker Product Overview
            10.2.3 Beckman Coulter Genomic Biomarker Product Market Performance
            10.2.4 Beckman Coulter Business Overview
            10.2.5 Beckman Coulter SWOT Analysis
            10.2.6 Beckman Coulter Recent Developments
      10.3 Myriad Genetics
            10.3.1 Myriad Genetics Basic Information
            10.3.2 Myriad Genetics Genomic Biomarker Product Overview
            10.3.3 Myriad Genetics Genomic Biomarker Product Market Performance
            10.3.4 Myriad Genetics Business Overview
            10.3.5 Myriad Genetics SWOT Analysis
            10.3.6 Myriad Genetics Recent Developments
      10.4 Thermo Fisher Scientific
            10.4.1 Thermo Fisher Scientific Basic Information
            10.4.2 Thermo Fisher Scientific Genomic Biomarker Product Overview
            10.4.3 Thermo Fisher Scientific Genomic Biomarker Product Market Performance
            10.4.4 Thermo Fisher Scientific Business Overview
            10.4.5 Thermo Fisher Scientific Recent Developments
      10.5 Roche
            10.5.1 Roche Basic Information
            10.5.2 Roche Genomic Biomarker Product Overview
            10.5.3 Roche Genomic Biomarker Product Market Performance
            10.5.4 Roche Business Overview
            10.5.5 Roche Recent Developments
      10.6 QIAGEN
            10.6.1 QIAGEN Basic Information
            10.6.2 QIAGEN Genomic Biomarker Product Overview
            10.6.3 QIAGEN Genomic Biomarker Product Market Performance
            10.6.4 QIAGEN Business Overview
            10.6.5 QIAGEN Recent Developments
      10.7 Epigenomics
            10.7.1 Epigenomics Basic Information
            10.7.2 Epigenomics Genomic Biomarker Product Overview
            10.7.3 Epigenomics Genomic Biomarker Product Market Performance
            10.7.4 Epigenomics Business Overview
            10.7.5 Epigenomics Recent Developments
      10.8 Almac
            10.8.1 Almac Basic Information
            10.8.2 Almac Genomic Biomarker Product Overview
            10.8.3 Almac Genomic Biomarker Product Market Performance
            10.8.4 Almac Business Overview
            10.8.5 Almac Recent Developments
      10.9 Pfizer
            10.9.1 Pfizer Basic Information
            10.9.2 Pfizer Genomic Biomarker Product Overview
            10.9.3 Pfizer Genomic Biomarker Product Market Performance
            10.9.4 Pfizer Business Overview
            10.9.5 Pfizer Recent Developments
      10.10 Human Longevity
            10.10.1 Human Longevity Basic Information
            10.10.2 Human Longevity Genomic Biomarker Product Overview
            10.10.3 Human Longevity Genomic Biomarker Product Market Performance
            10.10.4 Human Longevity Business Overview
            10.10.5 Human Longevity Recent Developments
      10.11 ValiRx
            10.11.1 ValiRx Basic Information
            10.11.2 ValiRx Genomic Biomarker Product Overview
            10.11.3 ValiRx Genomic Biomarker Product Market Performance
            10.11.4 ValiRx Business Overview
            10.11.5 ValiRx Recent Developments
      10.12 Personalis
            10.12.1 Personalis Basic Information
            10.12.2 Personalis Genomic Biomarker Product Overview
            10.12.3 Personalis Genomic Biomarker Product Market Performance
            10.12.4 Personalis Business Overview
            10.12.5 Personalis Recent Developments
      10.13 Eagle Genomics
            10.13.1 Eagle Genomics Basic Information
            10.13.2 Eagle Genomics Genomic Biomarker Product Overview
            10.13.3 Eagle Genomics Genomic Biomarker Product Market Performance
            10.13.4 Eagle Genomics Business Overview
            10.13.5 Eagle Genomics Recent Developments
      10.14 Empire Genomics
            10.14.1 Empire Genomics Basic Information
            10.14.2 Empire Genomics Genomic Biomarker Product Overview
            10.14.3 Empire Genomics Genomic Biomarker Product Market Performance
            10.14.4 Empire Genomics Business Overview
            10.14.5 Empire Genomics Recent Developments
      10.15 Agilent
            10.15.1 Agilent Basic Information
            10.15.2 Agilent Genomic Biomarker Product Overview
            10.15.3 Agilent Genomic Biomarker Product Market Performance
            10.15.4 Agilent Business Overview
            10.15.5 Agilent Recent Developments
      10.16 Illumina
            10.16.1 Illumina Basic Information
            10.16.2 Illumina Genomic Biomarker Product Overview
            10.16.3 Illumina Genomic Biomarker Product Market Performance
            10.16.4 Illumina Business Overview
            10.16.5 Illumina Recent Developments
  11 Genomic Biomarker Market Forecast by Region
      11.1 Global Genomic Biomarker Market Size Forecast
      11.2 Global Genomic Biomarker Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Genomic Biomarker Market Size Forecast by Country
            11.2.3 Asia Pacific Genomic Biomarker Market Size Forecast by Region
            11.2.4 South America Genomic Biomarker Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Genomic Biomarker by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Genomic Biomarker Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Genomic Biomarker by Type (2026-2033)
            12.1.2 Global Genomic Biomarker Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Genomic Biomarker by Type (2026-2033)
      12.2 Global Genomic Biomarker Market Forecast by Application (2026-2033)
            12.2.1 Global Genomic Biomarker Sales (K Units) Forecast by Application
            12.2.2 Global Genomic Biomarker Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400